These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29716811)

  • 1. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator.
    Meguro Y; Miyano K; Hirayama S; Yoshida Y; Ishibashi N; Ogino T; Fujii Y; Manabe S; Eto M; Nonaka M; Fujii H; Ueta Y; Narita M; Sata N; Yada T; Uezono Y
    J Pharmacol Sci; 2018 May; 137(1):67-75. PubMed ID: 29716811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.
    Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first structure-activity relationship study of oxytocin as a positive allosteric modulator for the µ opioid receptor.
    Mizuguchi T; Miyano K; Yamauchi R; Yoshida Y; Takahashi H; Yamazaki A; Ono H; Inagaki M; Nonaka M; Uezono Y; Fujii H
    Peptides; 2023 Jan; 159():170901. PubMed ID: 36347314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses.
    Manabe S; Miyano K; Fujii Y; Ohshima K; Yoshida Y; Nonaka M; Uzu M; Matsuoka Y; Sato T; Uezono Y; Morimatsu H
    J Pharmacol Sci; 2019 Jun; 140(2):171-177. PubMed ID: 31320243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ignavine: a novel allosteric modulator of the μ opioid receptor.
    Ohbuchi K; Miyagi C; Suzuki Y; Mizuhara Y; Mizuno K; Omiya Y; Yamamoto M; Warabi E; Sudo Y; Yokoyama A; Miyano K; Hirokawa T; Uezono Y
    Sci Rep; 2016 Aug; 6():31748. PubMed ID: 27530869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor.
    Schröder H; Wu DF; Seifert A; Rankovic M; Schulz S; Höllt V; Koch T
    Neuropharmacology; 2009 Mar; 56(4):768-78. PubMed ID: 19162047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
    Melkes B; Hejnova L; Novotny J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic fentanyl treatments induce the up-regulation of mu opioid receptor mRNA in rat pheochromocytoma cells.
    Yoshikawa M; Nakayama H; Ueno S; Hirano M; Hatanaka H; Furuya H
    Brain Res; 2000 Mar; 859(2):217-23. PubMed ID: 10719067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of mu opioid receptor gene by cAMP pathway.
    Lee PW; Lee YM
    Mol Pharmacol; 2003 Dec; 64(6):1410-8. PubMed ID: 14645671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner.
    Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE
    J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin under opioid antagonism leads to supralinear enhancement of social attention.
    Dal Monte O; Piva M; Anderson KM; Tringides M; Holmes AJ; Chang SWC
    Proc Natl Acad Sci U S A; 2017 May; 114(20):5247-5252. PubMed ID: 28461466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.
    Moreno E; Quiroz C; Rea W; Cai NS; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; Ferré S
    J Neurosci; 2017 Feb; 37(5):1176-1186. PubMed ID: 28007761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxytocin receptor system: structure, function, and regulation.
    Gimpl G; Fahrenholz F
    Physiol Rev; 2001 Apr; 81(2):629-83. PubMed ID: 11274341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Effects of Ligand Bias on Primate Mu Opioid Receptor Downstream Signaling.
    Zhang X; Hutchins SD; Blough BE; Vallender EJ
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A real-time, fluorescence-based assay for measuring μ-opioid receptor modulation of adenylyl cyclase activity in Chinese hamster ovary cells.
    Knapman A; Abogadie F; McIntrye P; Connor M
    J Biomol Screen; 2014 Feb; 19(2):223-31. PubMed ID: 23989451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells.
    Belcheva MM; Haas PD; Tan Y; Heaton VM; Coscia CJ
    J Pharmacol Exp Ther; 2002 Dec; 303(3):909-18. PubMed ID: 12438509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma membrane localization of the μ-opioid receptor controls spatiotemporal signaling.
    Halls ML; Yeatman HR; Nowell CJ; Thompson GL; Gondin AB; Civciristov S; Bunnett NW; Lambert NA; Poole DP; Canals M
    Sci Signal; 2016 Feb; 9(414):ra16. PubMed ID: 26861044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor endocytosis counteracts the development of opioid tolerance.
    Koch T; Widera A; Bartzsch K; Schulz S; Brandenburg LO; Wundrack N; Beyer A; Grecksch G; Höllt V
    Mol Pharmacol; 2005 Jan; 67(1):280-7. PubMed ID: 15475572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
    Cinar R; Szücs M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.